10 HIV Clinical Wins for 2015 and a tool box for good Sex
We can’t leave the year without again reviewing the latest developments in HIV for 2015 which has been a watershed year in that we have brought to light all the tools available for a person to stay HIV negative and an HIV+ to have normal sex without medical stigma. Up to now HIV men were not supposed to have sex according to many opinions including some HIV+ themselves. It is clear now that unless you live under a rock, you can stay negative and if you are Poz you can start normalizing your sexual life and if anyone does not agree they can just not have sex. If the clinical positive person is refused for stigma soon it will be seen as ignorance and not shame. The one that wants to but runs away when the truth is presented to him would have to deal with themselves of why the truth is bad and lies or not knowing is better. We should be smart and educated and try to live a full life which includes a healthy sex life, which includes not putting someone at risk including yourself. It is clear now you don’t have to. Know the tools and use them!
Who can complain about exciting, newer medications and novel ways to use them to treat HIV and hepatitis C (HCV), or new data that shed light on old issues such as the optimal timing of HIV therapy or the role of HIV in aging?
However, we can certainly do without the depressing news of an HIV and HCV outbreak in southern Indiana that was both predictable and preventable, or that the bold expansion of health care insurance is under attack by many who would rather score a victory against their political opponents than on behalf of the people they were elected to represent.
What is most interesting about the past year's events is how our wonderful capacity for invention and innovation is matched by our incredible and frustrating ability to screw things up.
So here are both the commendable and the concerning: my top 10 stories from 2015.
Table of Contents
- START at the Finish
- Tenofovir Alafenamide Fumarate (TAF) Is FDA Approved
- Dolutegravir Minimalism
- Long-Acting HIV Treatment Is No Longer a Long Shot
- Hepatitis C Cures in HIV/HCV Coinfection
- Real World PrEP
- Tragedy in Scott County, Indiana
- Evidence Against Accelerated Aging Among People Living With HIV
- Adverse Childhood Events and Risk for HIV
- King v. Burwell: U.S. Supreme Court Again Upholds Affordable Care Act
David Alain Wohl, M.D., is an associate professor of medicine in the Division of Infectious Diseases at the University of North Carolina and site leader of the University of North Carolina AIDS Clinical Trials Unit at Chapel Hill.
Comments